3-O-Methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 7, 2003, Pages 1004-1008

  Beuthien Baumann, B ^a   Bredow, J ^a   Burchert, W ^b   Fuchtner F ^b   Bergmann, R ^b   Alheit, H D ^a   Reiss, G ^a   Hliscs, R ^a   Steinmeier, R ^a   Franke, W G ^a   Johannsen, B ^b   Kotzerke, J ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

3 O Methyl 6 18F fluoro L DOPA; Amino acid derivative; Brain tumour; Dosimetry; Positron emission tomography

Indexed keywords

3 O METHYL 6 FLUORODOPA F 18; FLUORINE 18; FLUORINE DERIVATIVE; GALLIUM 68; LEVODOPA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE;

ADULT; AGED; BODY BURDEN; BRAIN NEOPLASMS; DIHYDROXYPHENYLALANINE; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; ORGAN SPECIFICITY; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0043194321     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1205-2     Document Type: Article

References (19)

1. Reske SN, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. Eur J Nucl Med 2001; 28:1707-1723.
2. 14C]fluorophenylalanine. J Neurochem 1988; 50:979-983.
3. 18F]fluorotyrosine, a new PET tracer of protein synthesis. J Nucl Med 1989; 30:1367-1372.
4. Inoue T, Tomiyoshi K, Higuichi T, et al. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent. J Nucl Med 1998; 39:663-667.
5. 18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 1999; 40:205-212.
6. 18F]fluoro-L-DOPA. Appl Radiat Isot 2003; 58:575-578.
7. Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Watanuki S. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med 1991; 32:699-706.
8. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37:538-546.
9. 18FDOPA-PET study in newborn piglets. J Perinat Med 2000; 28:54-60.
10. 18F]fluoro-L-dopa-a promising substance for tumour imaging. J Lab Compd Radiopharm 1999; 42 Suppl 1:S267-S269.
11. 11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 2000; 27:542-549.
12. 18F alpha-methyl tyrosine PET studies in patients with brain tumors. J Nucl Med 1999; 40:399-405.
13. 18F]6-fluoro-3-O-methyl-L-dopa in the human brain. J Cereb Blood Flow Metab 1994; 14:664-670.
14. 14C]-L-dopa after oral administration in rats. Br J Pharmacol 1974; 50:259-263.
15. 18F]fluoro-L-dopa in the rhesus monkey brain. J Cereb Blood Flow Metab 1991; 11:726-734.
16. 18F-FDG. J Nucl Med 2002; 43:210-214.
17. 11C]methionine using whole-body positron emission tomography. Eur J Nucl Med 1998; 25:629-633.
18. 18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging 2002; 29:1039-1046.
19. Watanabe H, Inoue T, Shinozaki T, et al. PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET. Eur J Nucl Med 2000; 27:1509-1517.